z-logo
open-access-imgOpen Access
Doxorubicin enhances 131 I-rituximab induced cell death in Raji cells
Author(s) -
Chandan Kumar,
B. N. Pandey,
Grace Samuel,
Meera Venkatesh
Publication year - 2015
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.140844
Subject(s) - raji cell , doxorubicin , apoptosis , rituximab , cancer research , programmed cell death , lymphoma , chemistry , microbiology and biotechnology , medicine , biology , chemotherapy , immunology , biochemistry
There are various therapeutic modalities of treatment for non-Hodgkin's lymphoma, but with certain limitations, hence, investigating the scope of combined therapeutic approach.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here